Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Flushing
ADR ID BADD_A01671
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.03      General signs and symptoms NEC
08.01.03.025      Flushing
23      Skin and subcutaneous tissue disorders
23.06      Skin vascular abnormalities
23.06.05      Skin vasomotor conditions
23.06.05.003      Flushing
24      Vascular disorders
24.03      Vascular disorders NEC
24.03.01      Peripheral vascular disorders NEC
24.03.01.002      Flushing
Description A disorder characterized by episodic reddening of the skin, especially face, neck, or chest. [CTCAE] A transient reddening of the face that may be due to fever, certain drugs, exertion, or stress. [MeSH]
MedDRA Code 10016825
MeSH ID D005483
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Facial flushing | Flushed | Flushed chest | Flushed face | Flushed skin | Flushing | Flushing of face | Generalised flushing | Gross flushing | Pallor and flushing | Skin flushed | Flushing aggravated | Generalized flushing | Flushings
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01143Immune globulin--
BADD_D01144Immunoglobulin (human)--
BADD_D01149Indapamide--
BADD_D01150Indinavir--
BADD_D01154Indium in-111 pentetreotide--
BADD_D01156Indomethacin--
BADD_D01157Infliximab--
BADD_D01162Insulin detemir--
BADD_D01166Interferon alfa-2a--
BADD_D01167Interferon alfa-2b--
BADD_D01172Iobenguane--
BADD_D01173Iobenguane i-123--
BADD_D01176Iodipamide--
BADD_D01177Iodipamide meglumine--
BADD_D01178Iodixanol0.193484%
BADD_D01180Iohexol0.314412%
BADD_D01181Iopamidol0.104567%
BADD_D01182Iopromide0.146536%
BADD_D01183Iothalamate meglumine--
BADD_D01184Iothalamic acid--
BADD_D01186Ioversol0.140134%
BADD_D01187Ioxaglate meglumine--
BADD_D01188Ioxaglic acid--
BADD_D01191Ipratropium--
BADD_D01193Ipratropium bromide monohydrate--
BADD_D01194Irbesartan0.000404%
BADD_D01195Irinotecan--
BADD_D01196Irinotecan hydrochloride--
BADD_D01197Iron0.000453%
BADD_D01198Iron dextran--
The 12th Page    First    Pre   12 13 14 15 16    Next   Last    Total 25 Pages
ADReCS-Target
ADR Term Drug Name Target